Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Lucas M. Kimmig
Chuanhong Liao
Remzi Bag
机构：
[1] The University of Chicago Medicine,Section of Pulmonary and Critical Care Medicine
[2] The University of Chicago,Department of Public Health Sciences
[3] The University of Chicago,Biological Sciences Division
来源：
Lung | 2020年 / 198卷
关键词：
Pulmonary arterial hypertension; Prostacyclins; Prostanoids; Inhaled prostanoids; Transition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：53 / 58
页数：5
相关论文
共 50 条
  • [21] SUCCESSFUL TRANSITION FROM PARENTERAL TO ORAL TREPROSTINIL WITHIN 24 HOURS IN PULMONARY ARTERIAL HYPERTENSION
    Ali, Ridaa
    Kashyap, Sarung
    Laroy, Valerie
    Shah, Poorvi
    Sunbuli, Moutaz
    Macaluso, Gregory
    Pauwaa, Sunil
    Sur, James
    Dia, Muhyaldeen
    CHEST, 2019, 156 (04) : 1704A - 1705A
  • [22] Inhaled treprostinil for treatment of chronic pulmonary arterial hypertension
    Voswinckel, R
    Ghofrani, HA
    Grimminger, F
    Seeger, W
    Olschewski, H
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (02) : 149 - 150
  • [23] Oral treprostinil for the treatment of pulmonary arterial hypertension in patients transitioned from parenteral or inhaled prostacyclins: case series and treatment protocol
    Coons, James C.
    Miller, Taylor
    Simon, Marc A.
    Ishizawar, David C.
    Mathier, Michael A.
    PULMONARY CIRCULATION, 2016, 6 (01) : 132 - 135
  • [24] Inhaled treprostinil sodium for the treatment of pulmonary arterial hypertension
    Ferrantino, Matthew
    White, R. James
    EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) : 2583 - 2593
  • [25] Impact of Parenteral Treprostinil Dosing in Pulmonary Arterial Hypertension
    Preston, I. R.
    Farber, H. W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S64 - S65
  • [26] Transition from treprostinil to selexipag in patients with pulmonary arterial hypertension: Case series
    Fanous, Sherif M.
    Janmohamed, Munir
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (23) : 1877 - 1881
  • [27] Triple Combination Therapy Including Inhaled Treprostinil in High Risk Patients with Pulmonary Arterial Hypertension Unsuited for Infused Prostanoid Therapy
    Swisher, J.
    Overton-Barnes, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [28] Real-world Transition and Persistence to Oral Treprostinil Therapy From Parenteral Prostacyclins in Patients With Pulmonary Arterial Hypertension
    Ataya, A.
    Seaman, S.
    Classi, P.
    Wu, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [29] Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series
    Enderby, C. Y.
    Soukup, M.
    Al Omari, M.
    Zeiger, T.
    Burger, C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (05) : 496 - 500
  • [30] Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
    Kuwana, Masataka
    Abe, Kohtaro
    Kinoshita, Hideyuki
    Matsubara, Hiromi
    Minatsuki, Shun
    Murohara, Toyoaki
    Sakao, Seiichiro
    Shirai, Yuichiro
    Tahara, Nobuhiro
    Tsujino, Ichizo
    Takahashi, Kenta
    Kanda, Shingo
    Ogo, Takeshi
    PULMONARY CIRCULATION, 2023, 13 (01)
12345